Author

Mohamad Nayal

Howard Hughes Medical Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Adam Daniels· 1 shared Apolonia GardneriD· 1 shared Ariel A. HippeniD· 1 shared Ashley Carter· 1 shared Brian M. Kelly· 1 shared Christin M. HongiD· 1 shared Christine C. WuiD· 1 shared Christine Ott· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adam Daniels

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage

Apolonia Gardner, Shuai Wang, Adam Daniels, Dan Dan Li, Christine C. Wu, Lucas Lin, Christin M. Hong, Sophia R. Zhao, Richard T. Born, Kamil Kruczek, Genevieve Weist, Laura Barrio Real, Joan Wicks, Mohamad Nayal, Ashley Carter, , Constance L. Cepko

This paper tests AAV8/Best1-Nrf2 gene therapy in rodent models of oxidative stress, showing protection of retinal cells and preservation of visual function.

Molecular Therapy · Feb 6, 2026Peer-reviewedPharmacology & Toxicology

Administration of barcoded AAV capsid library to the putamen of non-human primates identifies variants with efficient retrograde transport

Yulia Dzhashiashvili, Jodi L. McBride, Emily B. Fabyanic, Xin Huang, Brian M. Kelly, Greglynn D Walton-Gibbs, Vimala Vemireddi, Joan R. Wicks, Mohamad Nayal, Ariel A. Hippen, Zhenming Yu, Pichai Raman, Elizabeth A. Ramsburg, Marcus Davidsson, Esteban A. Engel, Tomas Björklund

The paper tests AAV capsid variants in non-human primates to identify those with improved retrograde transport properties.

Molecular Therapy · Dec 10, 2025Peer-reviewedNeuroscience